- Home
- SEMR vs OCUL Comparison
SEMR vs OCUL Comparison
Compare SEMR & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEMR
- OCUL
- Stock Information
- Founded
- SEMR 2008
- OCUL 2006
- Country
- SEMR United States
- OCUL United States
- Employees
- SEMR N/A
- OCUL N/A
- Industry
- SEMR EDP Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- SEMR Technology
- OCUL Health Care
- Exchange
- SEMR Nasdaq
- OCUL Nasdaq
- Market Cap
- SEMR 1.5B
- OCUL 1.4B
- IPO Year
- SEMR 2021
- OCUL 2014
- Fundamental
- Price
- SEMR $8.88
- OCUL $8.13
- Analyst Decision
- SEMR Buy
- OCUL Strong Buy
- Analyst Count
- SEMR 8
- OCUL 10
- Target Price
- SEMR $17.00
- OCUL $16.11
- AVG Volume (30 Days)
- SEMR 983.7K
- OCUL 2.5M
- Earning Date
- SEMR 08-04-2025
- OCUL 08-06-2025
- Dividend Yield
- SEMR N/A
- OCUL N/A
- EPS Growth
- SEMR N/A
- OCUL N/A
- EPS
- SEMR 0.05
- OCUL N/A
- Revenue
- SEMR $396,021,000.00
- OCUL $59,647,000.00
- Revenue This Year
- SEMR $21.84
- OCUL N/A
- Revenue Next Year
- SEMR $18.46
- OCUL $20.05
- P/E Ratio
- SEMR $186.67
- OCUL N/A
- Revenue Growth
- SEMR 22.75
- OCUL N/A
- 52 Week Low
- SEMR $7.90
- OCUL $5.79
- 52 Week High
- SEMR $18.74
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- SEMR 34.58
- OCUL 48.84
- Support Level
- SEMR $8.96
- OCUL $8.44
- Resistance Level
- SEMR $9.40
- OCUL $9.41
- Average True Range (ATR)
- SEMR 0.36
- OCUL 0.47
- MACD
- SEMR -0.12
- OCUL -0.06
- Stochastic Oscillator
- SEMR 3.78
- OCUL 17.42
About SEMR SEMrush Holdings Inc.
SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.